<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/uk-health-security-agency">
      <span class="gem-c-organisation-logo__name">UK Health<br>Security<br>Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Research and analysis
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    Variants: distribution of case data, 25 March 2022
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 25 March 2022</p>

  </header>



<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">
    <div class="govuk-grid-column-one-quarter-from-desktop contents-list-container">
        <nav aria-label="Contents" class="gem-c-contents-list" data-module="gem-track-click" role="navigation">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 1" data-track-category="contentsClicked" data-track-label="#differences-between-a-variant-of-concern-and-a-variant-under-investigation" data-track-options="{&quot;dimension29&quot;:&quot;Differences between a variant of concern and a variant under investigation&quot;}" href="#differences-between-a-variant-of-concern-and-a-variant-under-investigation">Differences between a variant of concern and a variant under investigation</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 2" data-track-category="contentsClicked" data-track-label="#changes-in-nomenclature" data-track-options="{&quot;dimension29&quot;:&quot;Changes in nomenclature&quot;}" href="#changes-in-nomenclature">Changes in nomenclature</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 3" data-track-category="contentsClicked" data-track-label="#note-on-omicron-voc-21nov-01-and-vui-22jan-01" data-track-options="{&quot;dimension29&quot;:&quot;Note on Omicron (VOC-21NOV-01 and VUI-22JAN-01)&quot;}" href="#note-on-omicron-voc-21nov-01-and-vui-22jan-01">Note on Omicron (VOC-21NOV-01 and VUI-22JAN-01)</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 4" data-track-category="contentsClicked" data-track-label="#alpha" data-track-options="{&quot;dimension29&quot;:&quot;Alpha&quot;}" href="#alpha">Alpha</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 5" data-track-category="contentsClicked" data-track-label="#beta" data-track-options="{&quot;dimension29&quot;:&quot;Beta&quot;}" href="#beta">Beta</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 6" data-track-category="contentsClicked" data-track-label="#gamma" data-track-options="{&quot;dimension29&quot;:&quot;Gamma&quot;}" href="#gamma">Gamma</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 7" data-track-category="contentsClicked" data-track-label="#delta" data-track-options="{&quot;dimension29&quot;:&quot;Delta&quot;}" href="#delta">Delta</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 8" data-track-category="contentsClicked" data-track-label="#vui-21oct-01" data-track-options="{&quot;dimension29&quot;:&quot;\nVUI-21OCT-01&quot;}" href="#vui-21oct-01">
VUI-21OCT-01</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 9" data-track-category="contentsClicked" data-track-label="#omicron" data-track-options="{&quot;dimension29&quot;:&quot;Omicron&quot;}" href="#omicron">Omicron</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 10" data-track-category="contentsClicked" data-track-label="#zeta" data-track-options="{&quot;dimension29&quot;:&quot;Zeta&quot;}" href="#zeta">Zeta</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 11" data-track-category="contentsClicked" data-track-label="#kappa" data-track-options="{&quot;dimension29&quot;:&quot;Kappa&quot;}" href="#kappa">Kappa</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 12" data-track-category="contentsClicked" data-track-label="#vui-21may-02" data-track-options="{&quot;dimension29&quot;:&quot;\nVUI-21MAY-02&quot;}" href="#vui-21may-02">
VUI-21MAY-02</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 13" data-track-category="contentsClicked" data-track-label="#lambda" data-track-options="{&quot;dimension29&quot;:&quot;Lambda&quot;}" href="#lambda">Lambda</a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 14" data-track-category="contentsClicked" data-track-label="#omicron-ba2-vui-22jan-01" data-track-options="{&quot;dimension29&quot;:&quot;Omicron BA.2 (VUI-22JAN-01)&quot;}" href="#omicron-ba2-vui-22jan-01">Omicron BA.2 (VUI-22JAN-01)</a>

        </li>
    </ol>
</nav>
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-e98134ae65ff5fe99a524d8c383350b3998f91c298dc24b36126e65f1656c578.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/covid-19-variants-genomically-confirmed-case-numbers/variants-distribution-of-case-data-25-march-2022
</p>


    </div>
  </div>

  <div class="main-content-container">
    <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
      <div class="govspeak">
<h3>Surveillance overview</h3>

<p>From 31 January 2022, the UK Health Security Agency (<abbr title="UK Health Security Agency">UKHSA</abbr>) has reported episodes of infection in its coronavirus (COVID-19) surveillance. Previous surveillance of COVID-19 in England was based on positive samples from the same person grouped together, so that the person was only counted once and reported using the date of the first positive result.</p>

<p>The ‘episode’ definition introduced groups positive results up to and including 90 days apart into episodes. Positive test results which are more than 90 days apart will be classed as separate episodes.</p>

<p>The <abbr title="UK Health Security Agency">UKHSA</abbr> methodology for reporting of COVID-19 cases varies between England and the devolved authorities. England and Scotland report 90-day infection episodes. Wales reports 42-day infection episodes. Northern Ireland reports data at individual level (only one infection episode is reported per person) but is working towards reporting 90-day infection episodes.</p>

<p>Information pertaining to <abbr title="variant under investigation">VUI</abbr>-21MAR-01, B1.324.1 with E484K has been removed as this variant has been reclassified as provisionally extinct. Variants <abbr title="variant under investigation">VUI</abbr>-21FEB-01 (A.23.1 with E484K), and <abbr title="variant of concern">VOC</abbr>-21FEB-02 (Alpha with E484K) are provisionally extinct (not detected for 12 weeks in the UK or in GISAID) therefore are no longer being included in the publication since 12 November 2021. Variant <abbr title="variant under investigation">VUI</abbr>-21MAY-01, AV.1 has been removed as of 3 December 2021 as it has been classified as provisionally extinct. Variant <abbr title="variant under investigation">VUI</abbr>-21JUL-01 (Mu) has been removed as of 17 February 2022 as it has been classified as provisionally extinct.</p>

<h3>UK total distribution for variants with new reports in the last 90 days</h3>

<table>
  <thead>
    <tr>
      <th scope="col">Variant</th>
      <th scope="col">Other names by which this variant may be known*</th>
      <th scope="col">Lineage</th>
      <th scope="col">Total confirmed (sequencing) and probable (genotyping) cases** ^</th>
      <th scope="col">New cases since last update (data up to 16 March 2022)</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Alpha</td>
      <td>
<abbr title="variant of concern">VOC</abbr>-20DEC-01</td>
      <td>B.1.1.7</td>
      <td>281,254</td>
      <td>+125</td>
    </tr>
    <tr>
      <td>Delta<sup>+</sup>
</td>
      <td>
<abbr title="variant of concern">VOC</abbr>-21APR-02</td>
      <td>B.1.617.2 AY.1    AY.2</td>
      <td>1,731,947<sup>+</sup>
</td>
      <td>-111<sup>†</sup>
</td>
    </tr>
    <tr>
      <td>
<abbr title="variant under investigation">VUI</abbr>-21OCT-01***</td>
      <td>
<abbr title="variant under investigation">VUI</abbr>-21OCT-01</td>
      <td>AY.4.2</td>
      <td>123,431</td>
      <td>-28</td>
    </tr>
    <tr>
      <td>Omicron</td>
      <td>
<abbr title="variant of concern">VOC</abbr>-21NOV-01</td>
      <td>B.1.1.529</td>
      <td>2,031,601</td>
      <td>+91,203</td>
    </tr>
    <tr>
      <td>Omicron BA.2</td>
      <td>
<abbr title="variant under investigation">VUI</abbr>-22JAN-01</td>
      <td>B.1.1.529.BA.2</td>
      <td>220,326</td>
      <td>+84,577</td>
    </tr>
  </tbody>
</table>

<p>*<abbr title="World Health Organization">WHO</abbr> naming has been included where available.</p>

<p>**Cumulative numbers may be revised up or down as a result of reclassification of results, re-infections and changes to diagnostic tests, new variants or public health management levels.</p>

<p>&nbsp;^Confirmed individuals are confirmed COVID-19 cases with a validated sequencing result meeting the confirmed case definitions outlined in the sections below. Probable individuals are confirmed COVID-19 cases with a genotyping result where sequencing confirmation is awaited or not available. Published figures include genotyping assay data for England, using a combination of highly specific mutations as an indicator of a probable variant. Genotyping assay data is currently only available for Alpha, Beta (for specimen dates up to and including 30 June 2021), Delta and Gamma.</p>

<p>+Of which 788 had the K417N mutation.</p>

<p>†Negative numbers driven by drop in genomically confirmed cases in Northern Ireland due to a change in analysis process, resulting in Delta cases before 1 September 2021 being excluded from the total count.</p>

<p>***Confirmed <abbr title="variant of concern">VOC</abbr>-21APR-02 with at least 2 <abbr title="variant under investigation">VUI</abbr>-21OCT-01 lineage defining positions called as alternate (variant) base and all other defining positions reported as N (unknown) or mixed bases.</p>

<h3>UK total distribution for variants detected in the UK with no or low<sup>$</sup> activity in the last 90 days</h3>

<table>
  <thead>
    <tr>
      <th scope="col">Variant</th>
      <th scope="col">Other names by which this variant may be known*</th>
      <th scope="col">Lineage</th>
      <th scope="col">Total confirmed (sequencing) and probable (genotyping) cases** ^</th>
      <th scope="col">Last reported specimen date$</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Beta<sup>¥</sup>
</td>
      <td>
<abbr title="variant of concern">VOC</abbr>-20DEC-02</td>
      <td>B.1.351</td>
      <td>1,064</td>
      <td>12 November 2021</td>
    </tr>
    <tr>
      <td>Gamma</td>
      <td>
<abbr title="variant of concern">VOC</abbr>-21JAN-02</td>
      <td>P.1</td>
      <td>295</td>
      <td>17 March 2022</td>
    </tr>
    <tr>
      <td>Zeta</td>
      <td>
<abbr title="variant under investigation">VUI</abbr>-21JAN-01</td>
      <td>P.2</td>
      <td>50</td>
      <td>14 April 2021</td>
    </tr>
    <tr>
      <td>Kappa</td>
      <td>
<abbr title="variant under investigation">VUI</abbr>-21APR-01</td>
      <td>B.1.617.1</td>
      <td>465</td>
      <td>14 September 2021</td>
    </tr>
    <tr>
      <td>
<abbr title="variant under investigation">VUI</abbr>-21MAY-02</td>
      <td>
<abbr title="variant under investigation">VUI</abbr>-21MAY-02</td>
      <td>C.36.3</td>
      <td>136</td>
      <td>26 June 2021</td>
    </tr>
    <tr>
      <td>Lambda</td>
      <td>
<abbr title="variant under investigation">VUI</abbr>-21JUN-01</td>
      <td>C.37</td>
      <td>8</td>
      <td>18 June 2021</td>
    </tr>
  </tbody>
</table>

<p>*<abbr title="World Health Organization">WHO</abbr> naming has been included where available.</p>

<p>**Cumulative numbers may be revised up or down as a result of reclassification of results, re-infections and changes to diagnostic tests, new variants or public health management levels.</p>

<p>&nbsp;^Confirmed individuals are confirmed COVID-19 cases with a validated sequencing result meeting the confirmed case definitions outlined in the sections below. Probable individuals are confirmed COVID-19 cases with a genotyping result where sequencing confirmation is awaited or not available. Published figures include genotyping assay data for England, using a combination of highly specific mutations as an indicator of a probable variant. Genotyping assay data is currently only available for Alpha, Beta (for specimen dates up to and including 30 June 2021), Delta and Gamma.</p>

<p><sup>$</sup>Fewer than 10 reports in any week during the last 90 days.</p>

<p><sup>¥</sup>Due to having identical genotyping profiles, since 1 July Beta and Mu cases identified by genotyping have been categorised as ‘Beta or Mu’. In addition to the above numbers, a further 23 ‘Beta or Mu’ provisional genotyping cases have been identified.</p>

<h2>Differences between a variant of concern and a variant under investigation</h2>

<p>SARS-CoV-2 variants, if considered to have concerning epidemiological, immunological or pathogenic properties, are raised for formal investigation. At this point they are designated variant under investigation (<abbr title="variant under investigation">VUI</abbr>) with a year, month, and number. Following a risk assessment with the relevant expert committee, they may be designated variant of concern (<abbr title="variant of concern">VOC</abbr>).</p>

<h2>Changes in nomenclature</h2>

<p>The previous variant names frequently include similar numbers with similar or repeating patterns. This makes referring to them verbally challenging. To overcome this challenge, a revised nomenclature has been agreed involving dropping the first 2 numbers of the year and replacing the 2-month numbers with a 3-letter abbreviation. This shortens the name and reduces the degree of repeated sequences of numbers. The table containing surveillance overview ‘UK total distribution’ contains a list of new variant names alongside previous or other names in use for <abbr title="variants of concern">VOCs</abbr> and <abbr title="variants under investigation">VUIs</abbr>.</p>

<h2>Note on Omicron (<abbr title="variant of concern">VOC</abbr>-21NOV-01 and <abbr title="variant under investigation">VUI</abbr>-22JAN-01)</h2>

<p>As genotyping assays cannot distinguish between BA.1 and BA.2 genomes, Omicron (<abbr title="variant of concern">VOC</abbr>-21NOV-01) includes cases of BA.1 and BA.2 genomes where those genomes were identified by genotyping only and not confirmed by genome sequencing.</p>

<h2>Alpha</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>230,398</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>9,287</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>29,125</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>12,444</td>
    </tr>
    <tr>
      <td><strong>Total cases</strong></td>
      <td><strong>281,254</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case with at least 5 <abbr title="variant of concern">VOC</abbr>-20DEC-01 lineage defining positions are called as alternate (variant) base and all other defining positions reported as N (unknown) or mixed bases</td>
    </tr>
    <tr>
      <td>Probable (genotyping)</td>
      <td>COVID-19* confirmed case with a genotyping result where sequencing confirmation is awaited or not available</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by polymerase chain reaction (<abbr title="polymerase chain reaction">PCR</abbr>).</td>
    </tr>
  </tbody>
</table>

<h2>Beta</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>950</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>9</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>62</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>43</td>
    </tr>
    <tr>
      <td><strong>Total cases</strong></td>
      <td><strong>1,064</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case where:<br> • at least 4 <abbr title="variant of concern">VOC</abbr>-20DEC-02 lineage defining positions are called as alternate (variant) base, and <br>• all other defining positions reported as N (unknown) or mixed bases <br> or<br> • at least 5 of the 9 non-synonymous changes</td>
    </tr>
    <tr>
      <td>Probable (genotyping)</td>
      <td>COVID-19* confirmed case with a genotyping result where sequencing confirmation is awaited or not available</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
    </tr>
  </tbody>
</table>

<h2>Gamma</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>270</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>0</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>23</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>2</td>
    </tr>
    <tr>
      <td><strong>Total cases</strong></td>
      <td><strong>295</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case with: <br>• at least 5 lineage defining non-synonymous changes called as alternate base, and <br>• all other positions either N or mixed bases</td>
    </tr>
    <tr>
      <td>Probable (genotyping)</td>
      <td>COVID-19* confirmed case with a genotyping result where sequencing confirmation is awaited or not available</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
    </tr>
  </tbody>
</table>

<h2>Delta</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>1,414,196</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>93,189</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>133,422</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>91,140</td>
    </tr>
    <tr>
      <td><strong>Total cases</strong></td>
      <td><strong>1,731,947</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed<br>(sequencing)</td>
      <td>COVID-19* confirmed case with at least 4 variant defining changes called as alternate base</td>
    </tr>
    <tr>
      <td>Probable (genotyping)</td>
      <td>COVID-19* confirmed case with a genotyping result where sequencing confirmation is awaited or not available</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
    </tr>
  </tbody>
</table>

<h2>
<abbr title="variant under investigation">VUI</abbr>-21OCT-01</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>94,009</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>748</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>13,638</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>15,036</td>
    </tr>
    <tr>
      <td>Total cases</td>
      <td><strong>123,431</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case that is confirmed <abbr title="variant of concern">VOC</abbr>-21APR-02 with at least 2 <abbr title="variant under investigation">VUI</abbr>-21OCT-01 lineage defining positions called as alternate (variant) base and all other defining positions reported as N (unknown) or mixed bases.</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
    </tr>
  </tbody>
</table>

<h2>Omicron</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>1,640,486</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>97,896</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>197,318</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>95,901</td>
    </tr>
    <tr>
      <td>Total cases</td>
      <td><strong>2,031,601</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case with at least 10 lineage defining non-synonymous changes called as alternate base and no more than 7 defining positions called as wild-type</td>
    </tr>
    <tr>
      <td>Probable (genotyping)</td>
      <td>COVID-19* confirmed case with a genotyping result where sequencing confirmation is awaited or not available</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
    </tr>
  </tbody>
</table>

<h2>Zeta</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>44</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>0</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>5</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>1</td>
    </tr>
    <tr>
      <td><strong>Total cases</strong></td>
      <td><strong>50</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* case confirmed as infected with <abbr title="variant under investigation">VUI</abbr>-21JAN-01 through whole genome sequencing (<abbr title="whole genome sequencing">WGS</abbr>) where: <br>• results of all lineage defining non-synonymous changes called as alternate base <br> or <br> • 6 of 7 non-synonymous changes called as alternate base, and<br>• remaining position either N or mixed bases</td>
    </tr>
    <tr>
      <td>Probable (genotyping)</td>
      <td>COVID-19* confirmed case with a genotyping result where sequencing confirmation is awaited or not available</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
    </tr>
  </tbody>
</table>

<h2>Kappa</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>419</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>4</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>27</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>15</td>
    </tr>
    <tr>
      <td><strong>Total cases</strong></td>
      <td><strong>465</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case with: <br>• at least 6** variant defining changes called as alternate base, and <br>• all other positions either N or mixed base</td>
    </tr>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
      <td>&nbsp;</td>
    </tr>
  </tbody>
</table>

<p>**Due to overlap with Delta sequences, the case definition of Kappa sequences was changed on 27 August 2021.</p>

<h2>
<abbr title="variant under investigation">VUI</abbr>-21MAY-02</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>125</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>3</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>4</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>4</td>
    </tr>
    <tr>
      <td>Total cases</td>
      <td><strong>136</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case with at least 5 variant defining changes called as alternate base, and <br>• all other positions either N or mixed base.</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
    </tr>
  </tbody>
</table>

<h2>Lambda</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>8</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>0</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>0</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>0</td>
    </tr>
    <tr>
      <td>Total cases</td>
      <td><strong>8</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case with at least 5 <abbr title="variant under investigation">VUI</abbr>-21JUN-01 lineage defining positions are called as alternate (variant) base and all other defining positions reported as N (unknown) or mixed bases.</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by <abbr title="polymerase chain reaction">PCR</abbr>.</td>
    </tr>
  </tbody>
</table>

<h2>Omicron BA.2 (<abbr title="variant under investigation">VUI</abbr>-22JAN-01)</h2>

<h3>Surveillance overview</h3>

<table>
  <thead>
    <tr>
      <td></td>
      <th scope="col">Total confirmed and probable cases</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>England</td>
      <td>168,500</td>
    </tr>
    <tr>
      <td>Northern Ireland</td>
      <td>6,545</td>
    </tr>
    <tr>
      <td>Scotland</td>
      <td>34,979</td>
    </tr>
    <tr>
      <td>Wales</td>
      <td>10,302</td>
    </tr>
    <tr>
      <td>Total cases</td>
      <td><strong>220,326</strong></td>
    </tr>
  </tbody>
</table>

<h4>Case definitions</h4>

<table>
  <thead>
    <tr>
      <th scope="col">Genomic match</th>
      <th scope="col">Criteria</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Confirmed <br>(sequencing)</td>
      <td>COVID-19* confirmed case with at least 10 lineage defining non-synonymous changes called as alternate base and no more than 3 defining positions called as wild-type.</td>
    </tr>
  </tbody>
</table>

<table>
  <tbody>
    <tr>
      <td>*A confirmed COVID-19 case: a case where the individual is confirmed to be infected with SARS-CoV-2 by polymerase chain reaction (<abbr title="polymerase chain reaction">PCR</abbr>).</td>
    </tr>
  </tbody>
</table>

</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>